CLINICAL_TRIALS trial_result · 2014-07-11

Clinical Trial Update: Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura [Phase 2]

Phase 2 study evaluating the safety and effectiveness of NXN-188 for migraine without aura has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: NeurAxon Inc. | Conditions: Migraine Without Aura | Phase 2 | Status: COMPLETED | Results posted: 2014-07-11